Alloga

Name

Alloga

Legal name

Alloga

Website

https://alloga-network.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Third-Party Logistics

NAICS

Warehousing and Storage (493), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Packaging and Labeling Services (56191)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Trucking & Courier Services (No Air) (4210)

akta.pro primary industry

Cold-Chain Packaging & Pack-Out Services (Gel Packs, Dry Ice, Insulated Shippers) (TLAIAGAK)

akta.pro secondary industries

Temperature-Controlled / Pharma Air Cargo Carriers (TLADAAAG), Cell Therapy Logistics & Chain-of-Identity/Chain-of-Custody (cold chain, tracking) (HLAAABAI)

Keywords

• Pharmaceutical logistics services
• Cold chain distribution
• Medical product warehousing
• GMP repackaging services
• Healthcare supply chain

Headquarters

HQ city

Weybridge

HQ country

United Kingdom

HQ region

Europe

Offices9 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D

Revenue model

1. Third-party logistics services: Alloga provides comprehensive 3PL services to pharmaceutical manufacturers including warehousing, distribution, freight management, order fulfillment, and value-added services such as repackaging, kitting, and labeling. Revenue is generated through long-term contractual relationships with pharma clients.
2. Cold-chain logistics: Specialized cold-chain storage and transportation services for temperature-sensitive pharmaceutical products including multi-layer packaging solutions and cross-border regulatory compliance management.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels1 record

Core offering

Alloga provides pharmaceutical third-party logistics (3PL) services to drug manufacturers across Europe, including temperature-controlled warehousing, domestic and international transport, order-to-cash fulfillment, GMP-compliant repackaging and relabeling, serialization, and specialized cold-chain handling for cell and gene therapies. The company operates 45 sites across 16 countries and combines transatlantic reach with sister company ICS (a Cencora subsidiary) for integrated US-Europe coverage.

Product overview

Alloga is a pharmaceutical third-party logistics (3PL) provider and subsidiary of Cencora, offering integrated logistics and warehousing services for pharmaceutical manufacturers across Europe. The core offering is Alloga's European 3PL Services, supplemented by specialized service modules including Warehousing and Storage Solutions, Transport Services, Order Fulfillment Services, Specialty Logistics/Cold Chain Solutions, Cell and Gene Therapy (CGT) Logistics, GMP Repacking and Relabeling, Pharmaceutical Serialization, API and Controlled Drug Logistics, Logistics Support for Import/Export, Fourth-Party Logistics (4PL), Title Model Solutions, and Full Order-to-Cash Solution. These services are supported by a Technology Enablement platform (multi-country portal, EDI integration, WMS, ERP). The company operates across multiple European countries including the UK, France, Germany, Spain, Netherlands, Austria, Switzerland, Portugal, Czech Republic, Lithuania, Norway, Romania, and Portugal, with UK operations centered in the East Midlands campus. Cencora has also expanded its European footprint through the acquisition of NextPharma Logistics covering Germany, Austria, and Switzerland.

Differentiator

Problem solved

Functional benefit

Products and services

• Alloga European 3PL Services Core integrated third-party logistics offering for pharmaceutical manufacturers across Europe, including warehousing, distribution, freight management, and order-to-cash services delivered through Alloga's 45-site network.
• Warehousing and Storage Solutions Pharmaceutical-grade warehousing with sophisticated refrigeration, specialized handling procedures, enhanced monitoring protocols, and efficient pick, pack, and ship operations for drug products.
• Transport Services Domestic and international transportation of pharmaceutical products with temperature controls, GDP-compliant methods, and track-and-trace portal with live shipment updates and ETAs.
• Order Fulfillment Services End-to-end order fulfillment including order-to-cash processes, with options for clients to retain customer interaction control or delegate full fulfillment and sales collection to Alloga.
• Specialty Logistics / Cold Chain Solutions Customized cold-chain storage solutions covering ambient to cryogenic temperatures, with specialized handling for aerosols, hazardous goods, APIs, and controlled drugs, maintaining cold-chain integrity throughout delivery.
• Cell and Gene Therapy (CGT) Logistics End-to-end storage and distribution for cell and gene therapy developers, supporting commercialization of advanced therapies through multi-layer packaging and real-time IoT temperature monitoring.
• GMP Repacking and Relabeling Specialized repackaging and relabeling services delivered under Good Manufacturing Practice (GMP) standards to uphold product integrity, patient safety, and quality.
• Pharmaceutical Serialization Services to maintain compliance with global pharmaceutical serialization requirements while delivering products to patients more efficiently.
• API and Controlled Drug Logistics Active pharmaceutical ingredient (API) supply chain and manufacturing logistics solutions designed to protect business continuity for controlled substances.
• Logistics Support for Import/Export Cross-border logistics support helping pharmaceutical products move efficiently and compliantly across international borders while mitigating risks and optimizing costs.
• Fourth-Party Logistics (4PL) Strategic, end-to-end fourth-party logistics supply chain management to improve visibility, coordination, compliance, and operational performance for pharmaceutical and healthcare organizations.
• Full Order-to-Cash Solution Combined supply chain and commercialization services that streamline operations, reduce risk, and help pharmaceutical manufacturers expedite cash flow.
• Technology Enablement Platform Technology platform supporting Alloga's 3PL services with a multi-country portal for international coordination, EDI integration for automated document exchange, Warehouse Management System, and ERP integration for unified operations visibility.

Quantifiable outcome

• Consolidated logistics partners can help pharma companies manage supply chain complexities more effectively
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Three partnerships are on record, tiered supporting and core.

• Europa (real estate investment firm)supportingOthers · 24 February 2026Europa, a pan-European real estate investment firm, owns the Panattoni Park J28 Central M1 development where Alloga took a 230,000 sq ft unit. Europa noted that strengthening demand for prime logistics units and constrained grade A supply along the M1 corridor have supported sustained rental growth.
• Super Smart Services (Chinese 3PL operator)supportingOthers · 24 February 2026Chinese 3PL operator occupying the other 345,000 sq ft unit at the same Panattoni Park J28 Central M1 development where Alloga took the 230,000 sq ft unit, completing full occupancy of the 575,000 sq ft development.
• ICS (subsidiary of Cencora)coreStrategic or Co-development PartnerAlloga and ICS, both subsidiaries of Cencora, combine their transatlantic logistics capabilities to deliver integrated 3PL services spanning warehousing, distribution, and freight management across the US and Europe. This partnership enables cost reduction and operational efficiency for pharma clients through consolidated logistics partners.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• ICS (Cencora US 3PL): Sister subsidiary within Cencora providing US pharmaceutical 3PL services. Directly comparable in model, customer base, and service scope, and explicitly combined with Alloga for transatlantic coverage.
• World Courier (Cencora): Cencora-owned specialty courier and clinical trial logistics provider. Highly comparable on cold-chain and high-value pharma handling, with overlapping cell-and-gene therapy capabilities that compete for the same clients.
• Movianto (Owens & Minor): European pharmaceutical 3PL operator offering warehousing, distribution, and cold-chain services to pharma manufacturers. Directly competes for European pharma manufacturer contracts alongside Alloga.
• TransCom Logistics (Pharma): European temperature-controlled freight and pharma logistics specialist. Comparable in cold-chain capability set and customer profile (pharma manufacturers), though typically smaller scale and more transport-focused than Alloga.
• Innomar (Cencora): Canadian specialty pharmaceutical 3PL/distributor within the Cencora family. Closely comparable in operating model (specialty pharma 3PL under Cencora) and adjacent to Alloga in North American specialty pharma logistics.

Broad incumbents

• DHL Supply Chain (Life Sciences & Healthcare): Global contract logistics incumbent with a dedicated Life Sciences & Healthcare vertical offering pharma warehousing, distribution, and cold-chain across Europe. Overlaps with Alloga's core 3PL offering but at much broader scale.
• Kuehne+Nagel (Pharma & Healthcare): Major global freight forwarder and contract logistics provider with a dedicated Pharma & Healthcare unit including temperature-controlled warehousing and distribution in Europe. Competes head-to-head for large pharma 3PL mandates.
• UPS Healthcare: Division of UPS offering pharmaceutical-grade warehousing, cold-chain, and distribution globally including in Europe. A scaled incumbent with similar temperature-controlled capabilities and broad geographic reach.
• DB Schenker (Life Sciences): European-headquartered global logistics provider with life sciences / pharma logistics capabilities including temperature-controlled storage and transport. Comparable broad incumbent for pharma manufacturer outsourcing.
• FedEx Custom Critical: FedEx unit specializing in temperature-sensitive and time-critical shipments including pharmaceuticals and biologics. Overlaps with Alloga's specialty transport and cold-chain positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/CencoraGlobal
• Facebookfacebook.com/Cencora
• LinkedInlinkedin.com/company/cencoraglobal
• Instagraminstagram.com/cencoraglobal

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alloga